C
Cellanome
Biotech & Life Sciences · Foster City, United States · Founded 2020
Cellanome is developing a unique multiomics platform to measure biology at an unprecedented resolution and scale MoreLess
Cellanome is a cutting-edge startup focused on revolutionizing the field of cell biology through its innovative automated platform. The company’s technology allows researchers to gain a deeper understanding of individual cell behaviors, interactions, and functions across a variety of conditions and parameters. This is achieved on a massive scale, enabling the study of numerous cells simultaneously.
The primary clients for Cellanome are researchers and professionals in the life sciences and medical fields. These clients benefit from the platform’s ability to perform live cell phenotypic and functional assays iteratively. This means that researchers can observe how cells react to different stimuli over time, providing a detailed view of cellular responses. Unlike traditional methods that often measure bulk responses, Cellanome’s platform highlights the unique reactions of individual cells, offering a more granular and precise analysis.
Operating in the biotechnology and life sciences market, Cellanome’s business model revolves around providing its platform as a service to research institutions, pharmaceutical companies, and biotech firms. The company generates revenue by offering subscriptions or licensing its technology, as well as through potential collaborations and partnerships with other entities in the field.
The platform is designed to integrate seamlessly into existing cell biology workflows, which means it can be easily adopted by labs without the need for significant changes to their current processes. This flexibility allows researchers to modify or create new live cell assays, making the platform a versatile tool in various experimental setups.
In summary, Cellanome is at the forefront of cell biology innovation, providing a powerful tool for researchers to explore cellular behaviors in unprecedented detail. The company’s focus on scalability and precision makes it a valuable asset in the life sciences and medical research communities.
Keywords: automated platform, cell biology, live cell assays, phenotypic analysis, functional assays, life sciences, medical research, biotechnology, cellular interactions, research innovation.
Company overview
Cellanome company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Foster City, United States
- Employees
- 123
- Open positions
- 15
- Dealroom signal
- 94.1
Valuation & funding
Cellanome funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jan 2024 | $150M | $600M | DCVC · 8VC | ↗ |
| SERIES AOther financing | Aug 2022 | $30M | $120M | Undisclosed | ↗ |
| SERIES AOther financing | Dec 2021 | $21M | $84M | Synetro Group | ↗ |
Growth signals
Cellanome website traffic
Latest recorded traffic for Cellanome is 4.5K monthly website visits, down 4.3% over the last three months. Cellanome's team grew 21.8% over the past year.
Hiring
Open positions at Cellanome
Current openings linked to this company in Dealroom.
Comparisons
Cellanome compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Cellanome's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Cellanome has talent and traffic
team presence
In the news
Latest news about Cellanome
Recent press, funding announcements, and product moves mentioning Cellanome — open to read from the original sources.
Market sentiment
What the market is saying about Cellanome
An AI-synthesized read of the highest-engagement posts about Cellanome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellanome’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










